Skip to content
ppharmaranks
Menu

AMPYRA vs DALFAMPRIDINE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Rating

New
New

Pharmacy pays

~$11.78 /30
~$11.78 /30

Type

RX
RX

Active ingredient

DALFAMPRIDINE
DALFAMPRIDINE

Manufacturer

Dosage forms

Tablet, extended release
Tablet, extended release

Drug class

Potassium Channel Blocker
Potassium Channel Blocker

Boxed warning

None
None

Treats

Multiple Sclerosis, Neurologic Gait Disorders
Multiple Sclerosis, Neurologic Gait Disorders

Frequently asked questions

Which is cheaper, Ampyra or Dalfampridine?

Pharmacies pay about the same to acquire either one — roughly $11.78 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Ampyra and Dalfampridine?

Both Ampyra and Dalfampridine share the active ingredient Dalfampridine.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.